400 related articles for article (PubMed ID: 20952683)
21. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
Cha S; Brayer J; Gao J; Brown V; Killedar S; Yasunari U; Peck AB
Scand J Immunol; 2004 Dec; 60(6):552-65. PubMed ID: 15584966
[TBL] [Abstract][Full Text] [Related]
22. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
[TBL] [Abstract][Full Text] [Related]
23. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelium and lymphocyte adhesion molecules in minor salivary glands of patients with Sjogren's syndrome.
Aziz KE; McCluskey PJ; Montanaro A; Wakefield D
J Clin Lab Immunol; 1992 Jan; 37(1):39-49. PubMed ID: 1339235
[TBL] [Abstract][Full Text] [Related]
25. Sex differences in a murine model of Sjögren's syndrome.
Ciháková D; Talor MV; Barin JG; Baldeviano GC; Fairweather D; Rose NR; Burek CL
Ann N Y Acad Sci; 2009 Sep; 1173():378-83. PubMed ID: 19758176
[TBL] [Abstract][Full Text] [Related]
26. Selective expression of V beta families by T cells in the blood and salivary gland infiltrate of patients with primary Sjögren's syndrome.
Smith MD; Lamour A; Boylston A; Lancaster FC; Pennec YL; van Agthoven A; Rook GA; Roncin S; Lydyard PM; Youinou PY
J Rheumatol; 1994 Oct; 21(10):1832-7. PubMed ID: 7837146
[TBL] [Abstract][Full Text] [Related]
27. Effector mechanism of experimental autoimmune sialadenitis in the mouse model for primary Sjögren's syndrome.
Hayashi Y; Haneji N; Hamano H; Yanagi K; Takahashi M; Ishimaru N
Cell Immunol; 1996 Aug; 171(2):217-25. PubMed ID: 8806790
[TBL] [Abstract][Full Text] [Related]
28. P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome.
Schrader AM; Camden JM; Weisman GA
Arch Oral Biol; 2005 Jun; 50(6):533-40. PubMed ID: 15848146
[TBL] [Abstract][Full Text] [Related]
29. Role of cytokines in the destruction of acinar structure in Sjögren's syndrome salivary glands.
Azuma M; Motegi K; Aota K; Hayashi Y; Sato M
Lab Invest; 1997 Sep; 77(3):269-80. PubMed ID: 9314950
[TBL] [Abstract][Full Text] [Related]
30. T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.
Li X; Li X; Qian L; Wang G; Zhang H; Wang X; Chen K; Zhai Z; Li Q; Wang Y; Harris DC
J Rheumatol; 2007 Dec; 34(12):2438-45. PubMed ID: 18050367
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
[TBL] [Abstract][Full Text] [Related]
32. Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice.
Li N; Shigihara T; Tzioufas AG; Notkins AL; Yoon JW; Jun HS
Arthritis Rheum; 2007 Jul; 56(7):2211-5. PubMed ID: 17599739
[TBL] [Abstract][Full Text] [Related]
33. The role of fractalkine as an accelerating factor on the autoimmune exocrinopathy in mice.
Tsubota K; Nishiyama T; Mishima K; Inoue H; Doi T; Hattori Y; Kodama T; Higuchi A; Hayashi Y; Saito I
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4753-60. PubMed ID: 19407023
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis and cell proliferation: the paradox of salivary glands in Sjögren's disease.
Herrera-Esparza R; Bollain-y-Goytia J; Ruvalcaba C; Ruvalcaba M; Pacheco-Tovar D; Avalos-Díaz E
Acta Reumatol Port; 2008; 33(3):299-303. PubMed ID: 18846009
[TBL] [Abstract][Full Text] [Related]
35. In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice.
Yanagi K; Haneji N; Hamano H; Takahashi M; Higashiyama H; Hayashi Y
Cell Immunol; 1996 Mar; 168(2):243-50. PubMed ID: 8640871
[TBL] [Abstract][Full Text] [Related]
36. The possible etiopathogenic genes of Sjögren's syndrome.
Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and prognostic value of quantitative immunohistological examination of lip biopsy in Sjögren's syndrome.
Bodeutsch C; de Wilde PC; Kater L; van den Hoogen FH; de Jong AJ; Borstlap WA; van de Putte LB; Vooijs GP
Neth J Med; 1991 Apr; 38(3-4):110-6. PubMed ID: 1881496
[TBL] [Abstract][Full Text] [Related]
38. Sjögren's syndrome salivary gland immunopathology: increased laminin expression precedes lymphocytic infiltration.
McArthur CP; Daniels PJ; Kragel P; Howard PF; Julian L
J Autoimmun; 1997 Feb; 10(1):59-65. PubMed ID: 9080300
[TBL] [Abstract][Full Text] [Related]
39. Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome?
Sellam J; Miceli-Richard C; Gottenberg JE; Proust A; Ittah M; Lavie F; Loiseau P; Mariette X
Rheumatology (Oxford); 2008 Apr; 47(4):437-41. PubMed ID: 18296721
[TBL] [Abstract][Full Text] [Related]
40. Central role for marginal zone B cells in an animal model of Sjogren's syndrome.
Shen L; Gao C; Suresh L; Xian Z; Song N; Chaves LD; Yu M; Ambrus JL
Clin Immunol; 2016 Jul; 168():30-36. PubMed ID: 27140729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
